纳米医学重塑瘤微环境用于固体瘤免疫疗法
Yuedong Guo1, Ping Hu1,2, Jianlin Shi2
1Shanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, School of Medicine, Tongji University, Shanghai 200331, P. R. China.
Journal of the American Chemical Society
|April 2, 2024
概括
纳米药物有望克服免疫抑制瘤微环境,这是固体瘤免疫治疗的主要障碍. 这种方法旨在逆转免疫抑制,提高固体瘤的治疗效率.
科学领域:
- 免疫学
- 癌症学
- 纳米技术
- 材料科学
背景情况:
- 免疫疗法对血液恶性瘤非常有效,但对固体瘤的疗效有限.
- 固体瘤具有独特的免疫抑制微环境,其特点是化学,细胞和物理障碍.
- 这些障碍包括缺氧,酸性,亲瘤性免疫细胞化和密集的物理组织结构,所有这些都阻碍了免疫治疗.
研究的目的:
- 突出有效免疫疗法逆转固体瘤的免疫抑制微环境的关键需求.
- 对基于纳米医学的重塑瘤免疫微环境策略的最新进展进行审查.
- 提供纳米医学在增强固体瘤免疫治疗中的作用的全面视角.
主要方法:
- 这一观点总结了固体瘤免疫疗法的纳米医学应用的近期进展.
- 它专注于纳米药物如何重塑瘤免疫微环境.
- 这篇评论讨论了纳米药物的独特特性 (形态,结构,组成),使微环境调节成为可能.
主要成果:
- 纳米药物提供了强大的工具来克服固体瘤微环境带来的挑战.
- 通过重塑免疫抑制因素,纳米药物可以增强免疫细胞活动和透.
- 这种重塑对于提高免疫治疗对固体瘤的疗效至关重要.
结论:
- 逆转免疫抑制性瘤微环境对于推进固体瘤免疫治疗至关重要.
- 基于纳米医学的方法正成为实现这一目标的有希望的策略.
- 这一领域在未来治疗固体瘤方面具有显著的潜力.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523


